Kent, Seamus http://orcid.org/0000-0001-7298-3163
Burn, Edward
Dawoud, Dalia
Jonsson, Pall
Østby, Jens Torup
Hughes, Nigel
Rijnbeek, Peter
Bouvy, Jacoline C.
Funding for this research was provided by:
Innovative Medicines Initiative (806968)
Article History
Accepted: 5 November 2020
First Online: 18 December 2020
Declarations
:
: The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
: JTØ is an employee of Pfizer, an international pharmaceutical company that develops and markets drugs in a number of therapeutic areas. NH is an employee and shareholder at the pharmaceutical company J&J. PR received unconditional grants from Janssen Research & Development and the Innovative Medicines Initiative during the conduct of this work. All other authors report no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.